Kymera Therapeutics, Inc.
KYMR
$117.39
$2.972.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.84% | 40.54% | 73.56% | -8.05% | 30.49% |
| Total Receivables | -50.00% | -- | -- | -- | 2,247.42% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 14.85% | 48.88% | 6.57% | 29.77% | 66.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.23% | 35.23% | 70.74% | -7.11% | 38.62% |
|
|
|||||
| Total Current Assets | 1.23% | 35.23% | 70.74% | -7.11% | 38.62% |
| Net Property, Plant & Equipment | -14.32% | -13.09% | -12.61% | -11.31% | -5.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.84% | 48.10% | 92.59% | 118.16% | 35.77% |
| Total Assets | 45.48% | 81.75% | 78.20% | 6.49% | 36.93% |
|
|
|||||
| Total Accounts Payable | 54.26% | 25.10% | -32.96% | -15.21% | -11.20% |
| Total Accrued Expenses | 73.28% | 51.81% | 21.24% | 7.95% | 17.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.22% | 3.72% | 4.91% | 6.94% | 10.07% |
| Total Finance Division Other Current Liabilities | -99.41% | -92.11% | 67.89% | 14.67% | 106.40% |
| Total Other Current Liabilities | -99.41% | -92.11% | 67.89% | 14.67% | 106.40% |
| Total Current Liabilities | -18.52% | 6.19% | 22.79% | 7.58% | 40.87% |
|
|
|||||
| Total Current Liabilities | -18.52% | 6.19% | 22.79% | 7.58% | 40.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.97% | -8.69% | -8.24% | -6.80% | -4.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -14.66% | -2.04% | 14.56% | 9.78% | 13.11% |
|
|
|||||
| Common Stock & APIC | 45.23% | 66.76% | 66.10% | 22.15% | 42.77% |
| Retained Earnings | -33.41% | -38.41% | -41.26% | -43.16% | -44.33% |
| Treasury Stock & Other | -2,665.23% | -7,131.03% | 221.21% | -22.27% | 113.29% |
| Total Common Equity | 55.36% | 95.82% | 89.04% | 5.97% | 41.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 55.36% | 95.82% | 89.04% | 5.97% | 41.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.36% | 95.82% | 89.04% | 5.97% | 41.84% |
|
|
|||||